Newsletter

Catalog

End-to-end logistics: the flagship theme of the 2017 edition of “Temperature Controlled Logistics”

02 January 2017

“Temperature
Controlled Logistics” is a European event which each year brings together those
involved in the logistical chain of healthcare products shipped via the cold
chain. This year the emphasis
will be placed on the security of cool chain end-to-end pharmaceutical
logistics.

End-to-end
pharmaceutical logistics: essential management

The end-to-end pharmaceutical
logistical chain, involves all of the logistical operations of medicines
(transport and storage) from the place of manufacture to delivery to healthcare
establishments (clinics, hospitals and pharmacies).

The transportation
of medicines in a temperature-controlled environment means that this end-to-end
pharmaceutical logistics via the cold chain must be perfectly
managed to guarantee the integrity of the medicines up until
they are administered to the patient. A particularly complex objective for
several reasons:

The number of
people involved in the logistics of medicines is high: manufacturers, carriers,
storage and distribution platforms, depositories, wholesalers-distributors and
lastly healthcare establishments (clinics, hospitals, pharmacies).

The circuits
are increasingly long and/or complex because the flows of healthcare
products are globalized prior to production, up to release from factories and
even warehouses. It is not uncommon today to see active pharmaceutical
ingredients (API) manufactured in India or China, converted into tablets or
vials for CMO (Contract Manufacturing Organizations) in the United States or
Canada, which are packaged in Europe and distributed around the world.

Regulations
for pharmaceutical companies have increased so as to
guarantee the security and integrity of healthcare products. The most obvious
example has been the GDP introduced by the European Commission in 2013, which
require medicines to be stored, transported and handled in accordance with
defined conditions. However, globalization is making
compliance with regulations even more complex. Compliance
with GDP is crucial but with other countries imposing their
own rules, it is not enough.

Sofrigam, the
partner for your end-to-end logistics

Variations in temperature during transportation can
partially or completely destroy a shipment and cause the pharmaceutical company
to lose millions of dollars.

Finding the most appropriate means of transport or even
choosing the most suitable insulated
packaging solutionis not easy. Today, there are many cold chain companies
and the range is varied, from the data logger to the refrigerated box including
active containers. Poor purchasing decisions can impact on the security of shipped healthcare products,
their quality, may not comply with regulations, resulting in company
losses and damage to its image.

Sofrigam benefits
from highly specialized expertise in the
pharmaceutical cold chain. As a partner of global pharmaceutical leaders
for almost 40 years, we assist them in securing their logistical chain from the
place of manufacture of medicines to patient administration. Our complete range of insulated solutions covers all
pharmaceutical logistics needs, from the pallet-shipper optimized for air
transportation to the insulated pouch intended to increase the security of the
medicine given to the patient. All of this, with a view to reducing costs and
the environmental impact using high-performance, innovative solutions.

Discover our
insulated packaging solutions on our stand (39/40) at the “Temperature
Controlled Logistics” event on 31st January and 1st
February 2017 in London. Our cold chain pharmaceutical experts will also be
there to respond to any of your shipping challenges!